K. Morii

Most-cited papers

1. Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating β-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody

   Yuki Katoh, T. Yaguchi, Akiko Kubo, Takashi Iwata +12 more

   2022Journal for ImmunoTherapy of Cancer105 citations Open access

   Semantic Scholar

   Save

2. Human PBMC-transferred murine MHC class I/II-deficient NOG mice enable long-term evaluation of human immune responses

   T. Yaguchi, Asuka Kobayashi, T. Inozume, K. Morii +8 more

   2017Cellular & Molecular Immunology69 citations Open access

   Semantic Scholar

   Save

3. GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab

   Daiki Kato, T. Yaguchi, T. Iwata, Yuki Katoh +12 more

   2020eLife56 citations Open access

   Semantic Scholar

   Save

4. Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia

   T. Iwata, Takuma Fujii, K. Morii, M. Saito +7 more

   2014International Journal of Clinical Oncology40 citations

   Semantic Scholar

   Save

5. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.

   Daiki Kato, T. Yaguchi, T. Iwata, K. Morii +3 more

   2017Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology26 citations Open access

   Semantic Scholar

   Save

6. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.

   N. Hirao, T. Iwata, Kohsei Tanaka, H. Nishio +10 more

   2019Gynecologic Oncology16 citations

   Semantic Scholar

   Save

7. Inhibition of vascular adhesion protein‐1 enhances the anti‐tumor effects of immune checkpoint inhibitors

   T. Kinoshita, M. Sayem, T. Yaguchi, B. Kharma +6 more

   2021Cancer Science12 citations Open access

   Semantic Scholar

   Save

8. Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancer

   Katsuhiro Ito, Kei Iida, Tomoko Hirano, Merrin Man Long Leong +13 more

   2026Nature Communications1 citations Open access

   Semantic Scholar

   Save

9. Abstract 907: Evaluation of the anti-GPC1 scFv-Fc fusion protein as a detection tool of GPC1 expression in human cancers

   Takeshi Sawada, T. Yaguchi, Y. Sakai, Chinatsu Suzuki +8 more

   2023Cancer Research0 citations

   Semantic Scholar

   Save

10. Peer Review #2 of "Engrailed-2 promotes a malignant phenotype of esophageal squamous cell carcinoma through upregulating the expression of pro-oncogenic genes (v0.2)"

    Yong Cao, Xiao-Yan Wang, Li Tang, Yan Li +243 more

    20200 citations Open access

    Semantic Scholar

    Save

11. Development of anti-GPC-1 (glypican-1)-CAR-T cells for adoptive T cell immunotherapies for squamous cell carcinoma

    T. Yaguchi, K. Morii, S. Serada, T. Naka +1 more

    2015Journal of Immunotherapy for Cancer0 citations Open access

    Semantic Scholar

    Save